Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.87% | -12.80% | -62.09% | -15.71% | -10.74% |
| Total Depreciation and Amortization | 2.30% | 2.35% | 325.00% | 122.22% | -18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.91% | 16.45% | 66.93% | 75.73% | 30.10% |
| Change in Net Operating Assets | 32.64% | 2,136.40% | 102.46% | -2,205.42% | -106.73% |
| Cash from Operations | 9.41% | 0.25% | -15.81% | -50.06% | -58.82% |
| Capital Expenditure | 23.08% | 27.78% | 95.77% | -89.53% | -5,712.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -549.67% | -4.18% | 119.03% | -27,718.01% | 98.63% |
| Cash from Investing | -549.94% | -4.16% | 118.96% | -19,018.72% | 97.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,729.36% | 1,199.10% | -99.62% | 19,439.52% | 182.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 773.80% | -- |
| Cash from Financing | 1,769.83% | 1,199.10% | -99.63% | 748.18% | 6,659.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -471.55% | 185.80% | 106.68% | -34,433.66% | 99.77% |